| 000 | 01976cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030721.0 | ||
| 008 | 121203s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2012.Wa.A | ||
| 100 | 0 | _aWalaa Abdelfattah Atya Elkak | |
| 245 | 1 | 0 |
_aAssociation of transforming growth factor Ý 1 gene polymorphism with natural clearance of hepatitis C virus / _cWalaa Abdelfattah Atya Elkak ; Supervised Mervat Saad Elansary , Ayatallah Amir Nassef , Hanan Abdelhalim Marzouk |
| 246 | 1 | 5 | _aالتحويلى بالتخلص الطبيعى من فيروس الكبدى الوبائى سىß1مدى ارتباط التنوع الشكلى الوظيفى لجين " عامل نمو |
| 260 |
_aCairo : _bWalaa Abdelfattah Atya Elkak , _c2012 |
||
| 300 |
_a154P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aHepatitis C is a disease with a significant global impact . According to the World Health Organzation there are 130 - 170 million people infected with hepatitis V virus . Although the initial infection is frequently asymptomatic , there are several subsequent clinical manifestations , including fibrosis of the liver , cirrhosis and hepatocellular carcinoma . The Egypt Demographic and Health Survery reported that the most recent report in 2008 had estimated a prevaence of 14.9 % | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHepatitis C virus | |
| 653 | 4 | _aPolymorphism | |
| 653 | 4 | _aTransforming growth factor beta | |
| 700 | 0 |
_aAyatallah Amir Nassef , _eSupervisor |
|
| 700 | 0 |
_aHanan Abdelhalim Marzouk , _eSupervisor |
|
| 700 | 0 |
_aMervat Saad Elansary , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40455 _d40455 |
||